Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Quint (London, United Kingdom), S. Arnetorp (Gothenburg, Sweden), C. Janson (Uppsala, Sweden), S. Boarino (Milan, Italy), J. Kocks (Groningen, Netherlands), I. Gilbert (Wilmington, DE, United States of America), M. Kupczyk (Lodz, Poland), J. Nuevo (Madrid, Spain), N. Lucia Lugogo (Ann Arbor, MI, United States of America), E. Penz (Saskatoon, Saskatchewan, Canada), S. Quirce (Madrid, Spain), C. Raherison-Semjen (Bordeaux, France), R. Van Der Valk (Cambridge, United Kingdom). Late Breaking Abstract - Short-acting ß2-agonist use in asthma in Western societies. 2629

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Overprescription of short-acting beta2-agonists in asthma management? Pharmacy reports from 91,673 patients in Poland Source: International Congress 2019 – New towards old therapies in airway diseases Year: 2019 Late Breaking Abstract - Patterns of inhaled corticosteroid-formoterol prescriptions in Poland Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts Year: 2019 Late Breaking Abstract - Overestimation of asthma control and misperception of short-acting ß2-agonists (SABA) use among physicians in Poland Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 Late Breaking Abstract - Real world patient-reported outcomes in asthma across six European countries: the NEWTON study Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021 Late Breaking Abstract - The burden of intermittent oral corticosteroid use in asthma Source: Virtual Congress 2021 – Asthma treatment: clinical and translational science Year: 2021 Late Breaking Abstract - E-cigarette use among Swedish teenagers Source: International Congress 2018 – Innovative tobacco cessation approaches and trends in tobacco and e-cigarette use Year: 2018 Late Breaking Abstract - Short-term and maintenance oral corticosteroid use for German patients with asthma Source: International Congress 2019 – Powerful cohort studies with/without lung function Year: 2019 Late Breaking Abstract - Pharmacological and clinical management of severe asthma in 9 countries: An international survey of clinicians. Source: Virtual Congress 2020 – Advances in asthma treatment Year: 2020 Late Breaking Abstract - Shared genetic origins of obesity and poor ICS response in children with asthma Source: Virtual Congress 2021 – Lung disease burden and management Year: 2021 Late Breaking Abstract - Oral corticosteroids exposure in a Swedish nationwide asthma population during 2006-2016 Source: International Congress 2018 – Does asthma phenotyping improve treatment? Year: 2018 Late Breaking Abstract - Early response to benralizumab in Canadians with severe eosinophilic asthma Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies Year: 2021 Late Breaking Abstract - Comparative analysis of effectiveness of Asthma Control Test-guided treatment versus usual care in patients with asthma from China Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 Late Breaking Abstract - Characterizing responders to benralizumab for severe asthma: pooled analysis of the SIROCCO and CALIMA studies Source: International Congress 2017 – Update and new perspectives in Airway Diseases Year: 2017 Late Breaking Abstract - Impact of maintenance and reliever therapy (MART)-focused asthma guideline on SABA prescriptions Source: Virtual Congress 2021 – Highlights for primary care in 2021 Year: 2021 Late Breaking Abstract - Comparative real world effectiveness of triple therapy versus dual bronchodilation in frequently exacerbating patients with COPD Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Late Breaking Abstract - Silent exacerbations: underreporting of COPD exacerbations in Poland Source: Virtual Congress 2020 – COPD and the impact of comorbidities Year: 2020 Late Breaking Abstract - Identifying and addressing patient beliefs driving SABA use and over-reliance Source: International Congress 2019 – Novel findings from asthma clinical trials Year: 2019 Late Breaking Abstract - Patients with severe eosinophilic asthma benefit from the treatment with Anti-IL-5 Reslizumab – a real life study from Austria Source: International Congress 2018 – Notable Studies in Asthma Year: 2018 Late Breaking Abstract - Improving adherence to prescribing remdesivir in COVID-19 Source: Virtual Congress 2021 – Respiratory infections Year: 2021 Late Breaking Abstract - The socio-economic cost of asthma, COPD and chronic bronchitis in Europe. Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer Year: 2017